-
Aslan Pharmaceuticals to Develop Aslan003 for Autoimmune Conditions
Please help me understand this statement from Dr. Delgado’s recently posted article:
“Aslan003 is a small molecule blocking the human enzyme” dihydroorotate dehydrogenase This enzyme is believed to reduce the activity of B-cells and T-cells Roboto; — immune cells that drive inflammation that can damage the nervous system in MS.”
If Aslan003 blocks the enzyme that reduces B-cell and T-cell activity, wouldn’t that be counter-intuitive for MS treatment and nervous system damage would continue via B-cell and T-cell activity?
Sorry, there were no replies found.
Log in to reply.